Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Executive Director, Omnichannel Strategy leads the portfolio-level digital and omnichannel strategy across HCP, patient, payer, and other relevant audiences. This role architects a digital-first operating model that scales across multiple indications while driving marketing-led AI use cases (e.g., next-best engagement, predictive audiences, creative modularity) exploration and adoption. Reporting to VP of US Sales and Marketing, this role transforms how we engage customers through integrated digital experiences while building capabilities for future growth.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Industry
Chemical Manufacturing
Number of Employees
501-1,000 employees